NantHealth Inc (NYSE:NH) announced its quarterly earnings results on Thursday. The company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.26) by $0.32, Morningstar.com reports. The company had revenue of $26.23 million for the quarter, compared to analysts’ expectations of $31.28 million. NantHealth had a negative net margin of 182.66% and a negative return on equity of 42.22%. The firm’s revenue was down 16.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.15) earnings per share.
NantHealth (NYSE NH) opened at 3.49 on Friday. The company’s 50-day moving average price is $4.23 and its 200 day moving average price is $4.82. The stock’s market capitalization is $425.62 million. NantHealth has a 12 month low of $2.94 and a 12 month high of $15.80.
ILLEGAL ACTIVITY NOTICE: “NantHealth Inc (NH) Announces Quarterly Earnings Results, Misses Estimates By $0.32 EPS” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/08/12/nanthealth-inc-nh-announces-quarterly-earnings-results-misses-estimates-by-0-32-eps.html.
A number of hedge funds have recently bought and sold shares of the company. TIAA CREF Investment Management LLC increased its position in shares of NantHealth by 68.6% in the first quarter. TIAA CREF Investment Management LLC now owns 20,200 shares of the company’s stock worth $100,000 after buying an additional 8,217 shares during the period. Bank of America Corp DE increased its position in shares of NantHealth by 366.4% in the first quarter. Bank of America Corp DE now owns 25,069 shares of the company’s stock worth $125,000 after buying an additional 19,694 shares during the period. Alliancebernstein L.P. acquired a new position in shares of NantHealth during the second quarter worth about $102,000. Teachers Advisors LLC increased its position in shares of NantHealth by 351.8% in the second quarter. Teachers Advisors LLC now owns 31,578 shares of the company’s stock worth $134,000 after buying an additional 24,588 shares during the period. Finally, GSA Capital Partners LLP acquired a new position in shares of NantHealth during the second quarter worth about $121,000.
Separately, Jefferies Group LLC reiterated a “buy” rating and set a $5.50 price target (down from $8.00) on shares of NantHealth in a research report on Monday, June 19th. Five research analysts have rated the stock with a buy rating, NantHealth currently has an average rating of “Buy” and an average target price of $9.45.
NantHealth Company Profile
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
What are top analysts saying about NantHealth Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for NantHealth Inc and related companies.